Contact Us
INTCO Medical 2025 Semi-Annual Report
2025-09-01
Strong Financial Growth in the First Half of 2025
In the first six months of 2025, INTCO Medical recorded steady expansion across revenue and profits.
-
Operating revenue reached RMB 4.913 billion, up 8.90% year on year.
-
Net profit attributable to shareholders was RMB 710 million, an increase of 21.02%.
-
Net cash flow from operating activities rose sharply to RMB 745 million, representing a growth of 170.15%.
-
By the end of June 2025, total assets stood at RMB 39.515 billion, an increase of 14.10%.
-
Shareholders’ equity was RMB 18.012 billion, up 3.50% from the previous year.
These results underline the company’s resilience and its ability to maintain strong momentum in a competitive global market.
Progress Across Five Strategic Pillars
Innovation and Research Achievements
During the reporting period, the company introduced 37 new products across medical consumables, rehabilitation equipment, and physical therapy solutions. Key highlights included the ECO manual wheelchair, the MOVO-F rollator, and the OBT04 over-bed table, all within the rehabilitation equipment category. These products share the qualities of being lightweight, practical, and designed to meet everyday rehabilitation and care needs, further strengthening the company’s presence in both professional medical channels and consumer markets.
Expanding Global Marketing Channels
INTCO strengthened its presence across social media and e-commerce ecosystems including Xiaohongshu, Douyin, Instagram, Facebook, Tmall, JD, and Douyin E-commerce. In addition, the company participated in 15 trade exhibitions covering 10 countries and regions, reinforcing its international visibility and brand influence.
Talent Development Initiatives
The company launched the “Yingcai Plan” in collaboration with Tsinghua University, attracting nearly 500 graduates in its first intake. This program builds a robust talent pipeline and injects new vitality into the organization.
Advancing Green Manufacturing
INTCO became the first domestic company in its sector to obtain Life Cycle Assessment (LCA) certification and carbon footprint certification for both nitrile and PVC disposable gloves. Its wind power project in Anhui was successfully connected to the grid, saving an estimated 6,246.5 tons of standard coal and reducing 17,154.5 tons of CO₂ emissions annually.
Recognition in ESG Performance
The company received several honors for its ESG contributions, including the Golden Antelope Award (2025 ESG Model Enterprise), the Silver Persimmon Award (2025 ESG Excellent Performance), and recognition as a 2025 Outstanding ESG Case in Shandong Province. Its disposable nitrile gloves were also named a Jiangxi Province Famous Brand Product. By July 2025, total charitable donations exceeded RMB 76 million, with continued involvement in local welfare initiatives such as nursing home support.
Outlook for the Future
INTCO Medical emphasized that the achievements of the first half of 2025 provide a strong foundation for full-year targets. Looking ahead, the company will continue to focus on its five strategic pillars—innovation, global market expansion, green manufacturing, talent development, and ESG leadership. Its long-term vision is to set new benchmarks in the healthcare industry and deliver greater value to global partners and consumers.
